Researchers at the NIH and Emory School of Medicine have completed the first minimally invasive coronary artery bypass of the ...

Purpose: Several aspects of the systemic inflammatory response to coronary artery bypass graft surgery are described.Summary. The inflammatory response is a fundamental biological protective mechanism ...

In a world-first, a team of researchers at the National Institutes of Health (NIH) and Emory School of Medicine, Atlanta, has successfully performed a coronary artery bypass — a normally open-heart ...

In a world-first, a team of researchers at the National Institutes of Health (NIH) and Emory School of Medicine, Atlanta, has successfully performed a coronary artery bypass - a normally open-heart ...

Women with severe coronary heart disease causing narrowing or blockages in the arteries may derive greater long-term benefits from coronary artery bypass grafting compared with percutaneous coronary ...

Add Yahoo as a preferred source to see more of our stories on Google. Blues Traveler frontman John Popper has had his share of health issues through the years, but what he faced in 2025 … well, the ...

Blues Traveler frontman John Popper has had his share of health issues through the years, but what he faced in 2025 … well, the singer told Rolling Stone that it nearly killed him. And the way he got ...

Please provide your email address to receive an email when new articles are posted on . Patients with prior bypass surgery who need PCI had better 1-year results when the procedure was performed on ...

Teams & Riders 'I have no doubt that I will be back at the same level as three years ago' – Christophe Laporte puts illnesses behind him to take aim at spring Classics Training Camps 'There were a few ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

About The Study: Although the incidence of new-onset atrial fibrillation (AF) after coronary artery bypass grafting (CABG) in this study was higher than previously reported, the AF burden in these ...

After coronary artery bypass grafting (CABG), evolocumab did not reduce saphenous vein graft disease rates at 2 years compared with placebo, according to late-breaking research presented in a Hot Line ...